Results 161 to 170 of about 516,933 (343)

Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2016
M. von Mehren, R. Randall, R. Benjamin, Sarah G. Boles, M. Bui, K. Ganjoo, S. George, R. Gonzalez, M. Heslin, J. Kane, V. Keedy, Edward Kim, H. Koon, J. Mayerson, M. McCarter, Sean V. McGarry, C. Meyer, Z. Morris, R. O'Donnell, A. Pappo, I. Paz, I. Petersen, J. Pfeifer, R. Riedel, B. Ruo, S. Schuetze, W. Tap, J. Wayne, Mary Anne Bergman, Jillian L. Scavone   +29 more
semanticscholar   +1 more source

Nanodroplet Array Platform for Integrated Synthesis and Screening of MEK Inhibitors: a Miniaturized Approach to Early Drug Discovery

Angewandte Chemie International Edition, EarlyView.
We present a nanodroplet array platform that integrates solid‐phase synthesis, MALDI‐MS analysis, and cell‐based screening. Using nanoliter droplets, we synthesized and tested 325 potential MEK inhibitors and identified 46 active compounds. This miniaturized approach combines chemistry and biology on a single chip, reducing time, cost, and material use
Maximilian Seifermann, Julius Höpfner, Liana Bauer, Divya Varadharajan, Stefan Schmidt, Björn Fröhlich, Benjamin Wellenhofer, Charlotte Luchena, Carsten Hopf, Anna A. Popova, Pavel A. Levkin   +10 more
wiley   +1 more source

Primary sarcoma arising in a cirrhotic liver [PDF]

, 1911
Humphry Rolleston, R. Salusbury Trevor
openalex   +1 more source

Review of the anatomical basis for predicting plutonium alpha particle radiation induced osteogenic cancers

The Anatomical Record, EarlyView.
Abstract Plutonium was discovered and first synthesized in the early 1940's. Several isotopes of plutonium are used in nuclear technologies, 238Pu for heat generation and 239Pu for energy production and weapons. Both isotopes emit alpha particles, which pose a significant radiation hazard when incorporated into the body.
Scott C. Miller
wiley   +1 more source

Primary sarcoma of the trachea [PDF]

, 1914
J. M. Ingersoll
openalex   +1 more source

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Blood, 1995
J. Soulier, L. Grollet, É. Oksenhendler, P. Cacoub, D. Cazals‐Hatem, P. Babinet, M. D'agay, J. Clauvel, M. Raphael, L. Degos, F. Sigaux   +10 more
semanticscholar   +1 more source

Sarcoma [PDF]

Proceedings of the Royal Society of Medicine, 1937
openaire   +2 more sources

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada

British Journal of Clinical Pharmacology, EarlyView.
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley   +1 more source

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan

British Journal of Clinical Pharmacology, EarlyView.
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang, Chen‐Han Chueh, Chien‐Yu Tseng, Christopher N. Kaufmann, Earl J. Morris, Chiao‐En Wu, Yi‐Wen Tsai   +6 more
wiley   +1 more source

Some genetical aspects of transplant-ability of the MY-mouse sarcoma

, 1958
Takaaki Ishihara, Tosihide H. YOSIDA
openalex   +2 more sources